Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts
- Supplementary File 1:
PDF-Document (PDF, 473 KiB)
Peltanova, B.; Liskova, M.; Gumulec, J.; Raudenska, M.; Polanska, H.H.; Vaculovic, T.; Kalfert, D.; Grega, M.; Plzak, J.; Betka, J.; Masarik, M. Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts. Int. J. Mol. Sci. 2021, 22, 1912. https://doi.org/10.3390/ijms22041912
Peltanova B, Liskova M, Gumulec J, Raudenska M, Polanska HH, Vaculovic T, Kalfert D, Grega M, Plzak J, Betka J, Masarik M. Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts. International Journal of Molecular Sciences. 2021; 22(4):1912. https://doi.org/10.3390/ijms22041912
Chicago/Turabian StylePeltanova, Barbora, Marketa Liskova, Jaromir Gumulec, Martina Raudenska, Hana H. Polanska, Tomas Vaculovic, David Kalfert, Marek Grega, Jan Plzak, Jan Betka, and Michal Masarik. 2021. "Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts" International Journal of Molecular Sciences 22, no. 4: 1912. https://doi.org/10.3390/ijms22041912